|
[1]
|
Shrivastava, S. and Conigliaro, R.L. (2023) Polycystic Ovarian Syndrome. The Medical Clinics of North America, 107, 227-234. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Li, R., Zhang, Q., Yang, D., et al. (2013) Prevalence of Polycystic Ovary Syndrome in Women in China: A Large Community-Based Study. Human Reproduction, 28, 2562-2569. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Patel, S. (2018) Polycystic Ovary Syndrome (PCOS), an Inflammatory, Systemic, Lifestyle Endocrinopathy. The Journal of Steroid Biochemistry and Molecular Biology, 182, 27-36. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Dabravolski, S.A., Nikiforov, N.G., Eid, A.H., et al. (2021) Mitochondrial Dysfunction and Chronic Inflammation in Polycystic Ovary Syndrome. International Journal of Molecular Sciences, 22, Article 3923. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Pang, Y., Wu, L., Tang, C., et al. (2022) Autophagy-Inflammation Interplay during Infection: Balancing Pathogen Clearance and Host Inflammation. Frontiers in Pharmacology, 13, Article 832750. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Metsios, G.S., Moe, R.H. and Kitas, G.D. (2020) Exercise and Inflammation. Best Practice & Research. Clinical Rheumatology, 34, Article ID: 101504. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Shamsi, M., Ghazavi, A., Saeedifar, A.M., et al. (2022) The Immune System’s Role in PCOS. Molecular Biology Reports, 49, 10689-10702. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Kakoly, N.S., Khomami, M.B., Joham, A.E., et al. (2018) Ethnicity, Obesity and the Prevalence of Impaired Glucose Tolerance and Type 2 Diabetes in PCOS: A Systematic Review and Meta-Regression. Human Reproduction Update, 24, 455-467. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Sadeghi, H.M., Adeli, I., Calina, D., et al. (2022) Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing. International Journal of Molecular Sciences, 23, Article 583. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Xing, C., Li, C. and He, B. (2020) Insulin Sensitizers for Improving the Endocrine and Metabolic Profile in Overweight Women with PCOS. The Journal of Clinical Endocrinology and Metabolism, 105, 2950-2963. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Garzia, E., Galiano, V., Marfia, G., et al. (2022) Hyperandrogenism and Menstrual Imbalance Are the Best Predictors of Metformin Response in PCOS Patients. Reproductive Biology and Endocrinology, 20, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Khichar, A., Gupta, S., Mishra, S., et al. (2021) Assessment of Inflammatory Markers in Women with PCOS and Their Correlation with Insulin Resistance. Clinical Laboratory, 67, 2439-2446. [Google Scholar] [CrossRef]
|
|
[13]
|
Mohammadian Khonsari, N., Baygi, F., Tabatabaei-Malazy, O., et al (2023) Association of Normal Weight Obesity Phenotype with Inflammatory Markers: A Systematic Review and Meta-Analysis. Frontiers in Immunology, 14, Article 1044178. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Stokkeland, L., Giskeødegård, G.F., Ryssdal, M., et al. (2022) Changes in Serum Cytokines throughout Pregnancy in Women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology and Metabolism, 107, 39-52. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Abraham Gnanadass, S., Divakar Prabhu, Y. and Valsala Gopalakrishnan, A. (2021) Association of Metabolic and Inflammatory Markers with Polycystic Ovarian Syndrome (PCOS): An Update. Archives of Gynecology and Obstetrics, 303, 631-643. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
He, S., Mao, X., Lei, H., et al. (2020) Peripheral Blood Inflammatory-Immune Cells as a Predictor of Infertility in Women with Polycystic Ovary Syndrome. Journal of Inflammation Research, 13, 441-450. [Google Scholar] [CrossRef]
|
|
[17]
|
ALhabardi, N.A., Al-Wutayd, O., Eltayieb, K.M., et al. (2020) Peripheral Hematological Parameters in Women with Polycystic Ovary Syndrome. The Journal of International Medical Research, 48, 1-6. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Gonzalez, F., Thusu, K., Abdel-Rahman, E., et al. (1999) Elevated Serum Levels of Tumor Necrosis Factor α in Normal-Weight Women with Polycystic Ovary Syndrome. Metabolism: Clinical and Experimental, 48, 437-441. [Google Scholar] [CrossRef]
|
|
[19]
|
Rudnicka, E., Kunicki, M., Suchta, K., et al. (2020) Inflammatory Markers in Women with Polycystic Ovary Syndrome. BioMed Research International, 2020, Article ID: 4092470. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Velez, L., M., Seldin, M. and Motta, A.B. (2021) Inflammation and Reproductive Function in Women with Polycystic Ovary Syndrome. Biology of Reproduction, 104, 1205-1217. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Yu, Y., Li, G., He, X., et al. (2021) MicroRNA-21 Regulate the Cell Apoptosis and Cell Proliferation of Polycystic Ovary Syndrome (PCOS) Granulosa Cells through Target Toll Like Receptor TLR8. Bioengineered, 12, 5789-5796. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Yan, S., Ding, J., Zhang, Y., et al. (2021) C1QTNF6 Participates in the Pathogenesis of PCOS by Affecting the Inflammatory Response of Granulosa Cells. Biology of Reproduction, 105, 427-438. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Lai, Y., Ye, Z., Mu, L., et al. (2022) Elevated Levels of Follicular Fatty Acids Induce Ovarian Inflammation via ERK1/2 and Inflammasome Activation in PCOS. The Journal of Clinical Endocrinology and Metabolism, 107, 2307-2317. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Liu, Y., Liu, H., Li, Z., et al. (2021) The Release of Peripheral Immune Inflammatory Cytokines Promote an Inflammatory Cascade in PCOS Patients via Altering the Follicular Microenvironment. Frontiers in Immunology, 12, Article ID: 685724. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Liu, Y., Li, Z., Wang, Y., et al. (2022) IL-15 Participates in the Pathogenesis of Polycystic Ovary Syndrome by Affecting the Activity of Granulosa Cells. Frontiers in Endocrinology, 13, Article 787876. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Ullah, A., Wang, M.J., Yang, J.P., et al. (2022) Ovarian Inflammatory MRNA Profiles of a Dehydroepiandrosterone plus High-Fat Diet-Induced Polycystic Ovary Syndrome Mouse Model. Reproductive Biomedicine Online, 44, 791-802. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Critchley, H., Maybin, J.A., Armstrong, G.M., et al. (2020) Physiology of the Endometrium and Regulation of Menstruation. Physiological Reviews, 100, 1149-1179. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Aksak, T., Gümürdülü, D., Çetin, M.T., et al. (2021) Expression of Monocyte Chemotactic Protein 2 and Tumor Necrosis Factor α in Human Normal Endometrium and Endometriotic Tissues. Journal of Gynecology Obstetrics and Human Reproduction, 50, Article ID: 101971. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Long, X., Li, R., Yang, Y., et al. (2017) Overexpression of IL-18 in the Proliferative Phase Endometrium of Patients with Polycystic Ovary Syndrome. Reproductive Sciences, 24, 252-257. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Peng, F., Hu, Y., Peng, S., et al. (2022) Apigenin Exerts Protective Effect and Restores Ovarian Function in Dehydroepiandrosterone Induced Polycystic Ovary Syndrome Rats: A Biochemical and Histological Analysis. Annals of Medicine, 54, 578-587. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Mousavi, R., Alizadeh, M., Asghari Jafarabadi, M., et al. (2022) Effects of Melatonin and/or Magnesium Supplementation on Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Biological Trace Element Research, 200, 1010-1019. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Areloegbe, S.E., Peter, M.U., Oyeleke, M.B., et al. (2022) Low-Dose Spironolactone Ameliorates Adipose Tissue Inflammation and Apoptosis in Letrozole-Induced PCOS Rat Model. BMC Endocrine Disorders, 22, Article No. 224. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Ullah, A., Pervaz, S., Adu-Gyamfi, E.A,, et al. (2022) CXCL13, and, CXCR5, Are, Upregulated, in, PCOS, Mice, Ovaries, But, Downregulated Following Metformin Administration. Molecular and Cellular Endocrinology, 556, Article ID: 111730. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Ryssdal, M., Vanky, E., Stokkeland, L., et al. (2023) Immunomodulatory Effects of Metformin Treatment in Pregnant Women with PCOS. The Journal of Clinical Endocrinology and Metabolism, 108, e743-e753. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Liang, Y., Xu, M.L., Gao, X., et al. (2023) Resveratrol Improves Ovarian State by Inhibiting Apoptosis of Granulosa Cells. Gynecological Endocrinology, 39, 2181652. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Ji, X., Ye, Y., Wang, L., et al. (2023) PDE4 Inhibitor Roflumilast Modulates Inflammation and Lipid Accumulation in PCOS Mice to Improve Ovarian Function and Reduce DHEA-Induced Granulosa Cell Apoptosis in Vitro. Drug Development Research, 84, 226-237. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Izadi, M., Rezvani, M.E., Aliabadi, A., et al. (2022) Mesenchymal Stem Cells-Derived Exosomes as a Promising New Approach for the Treatment of Infertility Caused by Polycystic Ovary Syndrome. Frontiers in Pharmacology, 13, Article 1021581. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Ibrahim, M., Sadek, M.T. and Sharaf Eldin, H. (2022) Role of Pomegranate Extract in Restoring Endometrial Androgen Receptor Expression, Proliferation, and Pinopodes in a Rat Model of Polycystic Ovary Syndrome. Morphologie, 106, 145-154. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Dokuzeylül, Güngör, N., Güngör, K., Yurci, A., et al. (2022) Ovarian Drilling Down-Regulates Endometrial Nuclear Factor-κB P65 Expression in Women with PCOS: A Prospective Case-Control Study. Turkish Journal of Obstetrics and Gynecology, 19, 45-50. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Escobar-Morreale, H.F. (2012) Surgical Management of Metabolic Dysfunction in PCOS. Steroids, 77, 312-316. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Hu, L., Ma, L., Xia, X., et al. (2022) Efficacy of Bariatric Surgery in the Treatment of Women with Obesity and Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology and Metabolism, 107, e3217-e3229. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Wang, X., Xu, T., Liu, R., et al. (2022) High-Fiber Diet Or Combined with Acarbose Alleviates Heterogeneous Phenotypes of Polycystic Ovary Syndrome by Regulating Gut Microbiota. Frontiers in Endocrinology, 12, Article 806331. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Elbandrawy, A.M., Yousef, A.M., Morgan, E.N., et al. (2022) Effect of Aerobic Exercise on Inflammatory Markers in Polycystic Ovary Syndrome: A Randomized Controlled Trial. European Review for Medical and Pharmacological Sciences, 26, 3506-3513.
|
|
[44]
|
Pandit, U., Singh, M., Ranjan, R., et al. (2022) The Effect of Exercise Training on Body Composition, Insulin Resistance and High Sensitivity C-Reactive Protein (Hs-CRP) in Women with Polycystic Ovary Syndrome: A Pilot Study from North India. Cureus, 14, e23994. [Google Scholar] [CrossRef] [PubMed]
|